Fanny Rocher
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Toxicology 11
- Pharmacovigilance and Adverse Drug Reactions 11
-
- Drug-Induced Adverse Reactions 5
- Drug-Induced Hepatotoxicity and Protection 3
- Co-authors
- Christine Lebrun‐Frénay (14 shared papers)Milou‐Daniel Drici (26 shared papers)Alexandre O. Gérard (21 shared papers)Audrey Fresse (8 shared papers)Nadège Parassol (7 shared papers)Laurent Chouchana (2 shared papers)Alexandre Destère (10 shared papers)Vincent Esnault (4 shared papers)
- Journals
- Neurology (2 papers)British Journal of Clinical Pharmacology (2 papers)Neurology and Therapy (2 papers)Journal of Clinical Medicine (2 papers)Kidney International Reports (1 paper)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Fanny Rocher
52 papers receiving 552 citations
Peers
Comparison fields: 5 of 91
- Toxicology 75
- Infectious Diseases 106
- Pathology and Forensic Medicine 98
- Neurology 59
- Oncology 74
Countries citing papers authored by Fanny Rocher
This map shows the geographic impact of Fanny Rocher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Rocher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Rocher more than expected).
Fields of papers citing papers by Fanny Rocher
This network shows the impact of papers produced by Fanny Rocher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Rocher. The network helps show where Fanny Rocher may publish in the future.
Co-authors
The 25 scholars most cited alongside Fanny Rocher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 103 | |
| 2 | 2018 | 70 | |
| 3 | 2020 | 49 | |
| 4 | 2022 | 31 | |
| 5 | 2018 | 29 | |
| 6 | 2023 | 23 | |
| 7 | 2020 | 16 | |
| 8 | 2020 | 16 | |
| 9 | 2010 | 16 | |
| 10 | 2020 | 14 | |
| 11 | 2022 | 14 | |
| 12 | 2019 | 13 | |
| 13 | 2021 | 11 | |
| 14 | 2007 | 11 | |
| 15 | 2022 | 10 | |
| 16 | 2020 | 10 | |
| 17 | 2018 | 9 | |
| 18 | 2021 | 9 | |
| 19 | 2017 | 9 | |
| 20 | 2015 | 8 |
About Fanny Rocher
Fanny Rocher is a scholar working on Toxicology, Pharmacology, Oncology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 59 papers that have together received 573 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (11 papers), Drug-Induced Adverse Reactions (5 papers), Polyomavirus and related diseases (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Multiple Sclerosis Research Studies (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). The work is most often cited by research in Toxicology (75 citations), Infectious Diseases (106 citations), Pathology and Forensic Medicine (98 citations), Neurology (59 citations) and Oncology (74 citations). Fanny Rocher has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Christine Lebrun‐Frénay, Milou‐Daniel Drici, Alexandre O. Gérard, Audrey Fresse, Nadège Parassol, Laurent Chouchana, Alexandre Destère, Vincent Esnault, Mikaël Cohen and Michel Lantéri‐Minet. Their work appears in journals such as Neurology, British Journal of Clinical Pharmacology, Neurology and Therapy, Journal of Clinical Medicine and Kidney International Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.